Should I buy BXP, Inc. (BXP) stock or is it too late?

BXP, Inc. · Real Estate · price $60

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Citigroup — 66% of its targets hit on this sector (194 calls tested). It aims for $69 (+15 %), call made on August 5, 2026, maturing on August 5, 2027 (70 d ago).

The 2 reliable analysts $78+30 %

The 10 other firms $71+18 %

How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $78 median. “The 10 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on BXP, Inc.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
JP Morgan	60 %	+12.6 %	10	$87 +45%
Argus Research	75 %	+6.1 %	8	$70 +17%
Barclays	63 %	+1.8 %	19	$79 +32%
Citigroup	20 %	-0.6 %	5	$69 +15%
Evercore ISI Group	42 %	-4.3 %	12	$67 +12%
Wells Fargo	33 %	-5.5 %	12	$82 +37%
Mizuho	25 %	-7.5 %	8	$68 +13%
Piper Sandler	25 %	-9.5 %	8	$72 +20%

In short — Should you invest in BXP, Inc.? Is it too late, still worth it? Analysts are fairly positive (58% buy, median target $71, i.e. +18%), and the most reliable on BXP targets even higher. But the valuation is stretched (P/E ~32). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $71, i.e. +18% from the current price ($60).
The most reliable firm on BXP, Barclays (63% hit rate, 19 scored calls), targets $79 (call made on July 21, 2026, maturing on July 21, 2027) (+32%) in its most recent call, and $78 (call made on December 1, 2025, maturing on December 1, 2026) (+30%) in the one coming due soonest.
Pays a dividend (4.1% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 12 ratings, 5 are neutral.
High valuation (P/E ~32): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on BXP

Median target $71 (+18%) · 12 ratings · Buy consensus

Strong Buy00%

Buy758%

Hold542%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in BXP, Inc. now?

We won't decide for you. The facts: 58% of analysts rate it a buy, median target $71 (+18%), and Barclays (most reliable on BXP, 63%) targets $79. Weigh that against valuation (P/E ~32). This is not personalized advice.

Is it too late to invest in BXP, Inc.?

Not according to analysts: the median target ($71) is still +18% above the current price ($60) (most reliable on BXP: Barclays, 63%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is BXP, Inc. still worth investing in?

It depends on the gap between the price ($60) and its estimated value: analysts target $71 on median (+18%), with 58% buys (most reliable on BXP: Barclays, 63%). Cross-check with their real reliability on BXP and the cautions above. Information, not advice.

What's the main risk in buying BXP?

The consensus is not unanimous: of 12 ratings, 5 are neutral.

→ Go deeper: the full BXP, Inc. profile (consensus, analyst reliability, price target, performance).